With so many kids already taking weight loss injectables like Ozempic, a new finding from the company behind the blockbuster weight loss drugs is looking to expand its pediatric market. In a new study ...
June 25 (Reuters) - (This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays. To receive the full newsletter in your inbox for free sign ...
The FDA has approved three new pediatric indications for somapacitan-beco, a once-weekly, long-acting growth hormone injection, according to a press release issued by Novo Nordisk.Somapacitan-beco ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results